Hikma's Advair Generic Gets Further Delayed Post author:Sam Post published:March 11, 2018 Post category:BioPharma Hikma Pharmaceuticals generic version of Advair has hit a stumbling block with the FDA. Source: BioSpace You Might Also Like A Look at the Deaths That Plagued Juno and Kite Pharma's CAR-T Trials June 26, 2017 Ex-Genentechers' Denali Scores $1B+ Alzheimer's Deal With Takeda January 4, 2018 Biogen To Present Data At July 13, 2017
